PubMed

Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance.

de Aguiar LG, Bahia LR, Villela N, Laflor C, Sicuro F, Wiernsperger N, Bottino D, Bouskela E.

Diabetes Care. 2006 May;29(5):1083-9.PMID: 16644641 [PubMed - indexed for MEDLINE]Related articlesFree article

Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome.

Kraemer de Aguiar LG, Laflor CM, Bahia L, Villela NR, Wiernsperger N, Bottino DA, Bouskela E.

Diabet Med. 2007 Mar;24(3):272-9.PMID: 17263761 [PubMed - indexed for MEDLINE]Related articles

Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

Clin Ther. 2005 Sep;27(9):1383-91.PMID: 16291411 [PubMed - indexed for MEDLINE]Related articles

[Vascular dysfunction in metabolic disorders: evaluation of some therapeutic interventions]

Bouskela E, Kraemer de Aguiar LG, Nivoit P, Bahia LR, Villela NR, Bottino DA.

Bull Acad Natl Med. 2007 Mar;191(3):475-92; discussion 492-3. French. PMID: 18072649 [PubMed - indexed for MEDLINE]Related articles

Improved endothelial function with metformin in type 2 diabetes mellitus.

Mather KJ, Verma S, Anderson TJ.

J Am Coll Cardiol. 2001 Apr;37(5):1344-50.PMID: 11300445 [PubMed - indexed for MEDLINE]Related articles

Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes.

Natali A, Baldeweg S, Toschi E, Capaldo B, Barbaro D, Gastaldelli A, Yudkin JS, Ferrannini E.

Diabetes Care. 2004 Jun;27(6):1349-57.PMID: 15161787 [PubMed - indexed for MEDLINE]Related articlesFree article

Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.

Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AF.

J Clin Pharm Ther. 2006 Aug;31(4):375-83.PMID: 16882108 [PubMed - indexed for MEDLINE]Related articles

Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.

Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves A.

Diabetes. 1999 Sep;48(9):1856-62.PMID: 10480619 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.

Tack CJ, Ong MK, Lutterman JA, Smits P.

Diabetologia. 1998 May;41(5):569-76.PMID: 9628275 [PubMed - indexed for MEDLINE]Related articles

Metabolic effects of chronic glipizide gastrointestinal therapeutic system on serum glucose, insulin secretion, insulin sensitivity, and hepatic insulin extraction in glucose-tolerant, first-degree relatives of African American patients with type 2 diabetes: new insights on mechanisms of action.

Osei K, Rhinesmith S, Gaillard T, Schuster D.

Metabolism. 2003 May;52(5):565-72.PMID: 12759885 [PubMed - indexed for MEDLINE]Related articles

Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.

Chazova I, Almazov VA, Shlyakhto E.

Diabetes Obes Metab. 2006 Jul;8(4):456-65.PMID: 16776753 [PubMed - indexed for MEDLINE]Related articles

3.5 years of insulin therapy with insulin glargine improves in vivo endothelial function in type 2 diabetes.

Vehkavaara S, Yki-Järvinen H.

Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):325-30. Epub 2003 Dec 18.PMID: 14684428 [PubMed - indexed for MEDLINE]Related articlesFree article

Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in C-reactive protein or fibrinogen.

Lima LM, Wiernsperger N, Kraemer-Aguiar LG, Bouskela E.

Clinics (Sao Paulo). 2009 Oct;64(5):415-20.PMID: 19488607 [PubMed - in process]Related articlesFree article

Short-term low-dosage pioglitazone treatment improves vascular dysfunction in patients with type 2 diabetes.

Maegawa H, Nishio Y, Nakao K, Ugi S, Maeda K, Uzu T, Kashiwagi A.

Endocr J. 2007 Aug;54(4):613-8. Epub 2007 Jul 20.PMID: 17641441 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of metformin on the glycemic control, lipid profile, and arterial blood pressure of type 2 diabetic patients with metabolic syndrome already on insulin.

Mourão-Júnior CA, Sá JR, Guedes OM, Dib SA.

Braz J Med Biol Res. 2006 Apr;39(4):489-94. Epub 2006 Apr 3.PMID: 16612472 [PubMed - indexed for MEDLINE]Related articlesFree article

Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in non-diabetic individuals with metabolic syndrome.

Bahia L, Aguiar LG, Villela N, Bottino D, Godoy-Matos AF, Geloneze B, Tambascia M, Bouskela E.

Atherosclerosis. 2007 Nov;195(1):138-46. Epub 2006 Nov 3.PMID: 17084402 [PubMed - indexed for MEDLINE]Related articles

Metformin improves endothelial function in patients with metabolic syndrome.

Vitale C, Mercuro G, Cornoldi A, Fini M, Volterrani M, Rosano GM.

J Intern Med. 2005 Sep;258(3):250-6.PMID: 16115299 [PubMed - indexed for MEDLINE]Related articles

Insulin therapy improves endothelial function in type 2 diabetes.

Vehkavaara S, Mäkimattila S, Schlenzka A, Vakkilainen J, Westerbacka J, Yki-Järvinen H.

Arterioscler Thromb Vasc Biol. 2000 Feb;20(2):545-50.PMID: 10669655 [PubMed - indexed for MEDLINE]Related articlesFree article

Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients.

Abbink EJ, Pickkers P, Jansen van Rosendaal A, Lutterman JA, Tack CJ, Russel FG, Smits P.

Diabet Med. 2002 Feb;19(2):136-43.PMID: 11874430 [PubMed - indexed for MEDLINE]Related articles

Effects of pioglitazone on endothelial function, insulin sensitivity, and glucose control in subjects with coronary artery disease and new-onset type 2 diabetes.

Sourij H, Zweiker R, Wascher TC.

Diabetes Care. 2006 May;29(5):1039-45.PMID: 16644634 [PubMed - indexed for MEDLINE]Related articlesFree article